← Eichor
Condition: Myelitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Myelitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT07251049China National Registry of Neuro-Inflammatory Diseases
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05154370Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Tianjin Medical University General Hospital · NCT07022197The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders
Phase 1 · 1 location(s) · Tongji Hospital · NCT06620809Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD
Phase N/A · 1 location(s) · Tongji Hospital · NCT06885957Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
Phase 3 · 33 location(s) · Mayo Clinic · NCT07100990Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations
Phase 4 · 3 location(s) · Sinovac Biotech Co., Ltd · NCT07354269Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT04106830Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine
Phase 4 · 3 location(s) · Sinovac Biotech Co., Ltd · NCT07457060Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06780709Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT06763848Evaluation of Patients With HAM/TSP
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT00001778Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh
Phase 2 · 1 location(s) · PATH · NCT05644184Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Phase N/A · 7 location(s) · Alexion Pharmaceuticals, Inc. · NCT06312644Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte My
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06865274A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
Phase 2/Phase 3 · 51 location(s) · Shanghai Jiaolian Drug Research and Development Co., Ltd · NCT06413654AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT04721717Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in
EARLY_Phase 1 · 1 location(s) · Tianjin Huanhu Hospital · NCT06939166Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Phase N/A · 3 location(s) · icometrix · NCT06280755Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)
EARLY_Phase 1 · 4 location(s) · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05145361Azathioprine in MOGAD
Phase 3 · 17 location(s) · Hospices Civils de Lyon · NCT05349006Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Phase N/A · 33 location(s) · Alexion Pharmaceuticals, Inc. · NCT05966467Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
Phase N/A · 13 location(s) · University of Bern · NCT05017142MS-ResearchBiomarkerS
Phase N/A · 1 location(s) · Cedars-Sinai Medical Center · NCT05204459Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama
Phase 2 · 3 location(s) · PATH · NCT05654467Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis
Phase N/A · 1 location(s) · University of Dublin, Trinity College · NCT05663008Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
NA · 1 location(s) · Jiangsu Province Centers for Disease Control and Prevention · NCT06605755Ofatumumab in AQP4-IgG Seropositive NMOSD
Phase 1/Phase 2 · 1 location(s) · Tang-Du Hospital · NCT05504694Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders
Phase 1/Phase 2 · 1 location(s) · Tianjin Medical University General Hospital · NCT05792462Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT06398158
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.